Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Diabetes Drugs Market


6. Market Share – Global Diabetes Drugs Market

6.1 By Disease Type
6.2 By Therapy

6.2.1 Oral Drugs
6.2.2 Injectable Drugs
6.2.3 Insulin

6.3 By Countries


7. Disease Type – Global Diabetes Drugs Market

7.1 Type 1 Diabetes Drug Market
7.2 Type 2 Diabetes Drug Market


8. Therapy – Global Diabetes Drugs Market

8.1 Oral Drugs

8.1.1 (DPP) IV inhibitor
8.1.2 SGLT – 2
8.1.3 Alpha Glucosidase Inhibitor
8.1.4 Biguanide
8.1.5 Others Oral Drug

8.2 Injectable Drugs

8.2.1 Glucagon-like peptide (GLP) 1 agonist
8.2.2 Amylin receptor agonist

8.3 Insulin

8.3.1 Rapid – Acting Insulin
8.3.2 Long Acting Insulin
8.3.3 Premixed Insulin
8.3.4 Other Insulin


9. Countries-Global Diabetes Drugs Market

9.1 North America

9.1.1 United States
9.1.2 Canada
9.1.3 Mexico

9.2 Latin America

9.2.1 Brazil

9.3 Europe

9.3.1 France
9.3.2 Germany
9.3.3 Italy
9.3.4 Spain
9.3.5 UK

9.4 Asia Pacific

9.4.1 Japan
9.4.2 South Korea
9.4.3 China
9.4.4 India
9.4.5 Australia
9.4.6 Vietnam
9.4.7 Malaysia
9.4.8 Indonesia
9.4.9 Philippines
9.4.10 Thailand

9.5 Middle East & Africa

9.5.1 Saudi Arabia
9.5.2 Iran
9.5.3 Oman
9.5.4 Egypt
9.5.5 South Africa


10. Porter’s Five Analysis- Global Diabetes Drugs Market

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis- Global Diabetes Drugs Market

11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat



12. Key Players Analysis

12.1 Novo Nordisk

12.1.1 Overview
12.1.2 Recent Development
12.1.3 SWOT Analysis
12.1.4 Sales Analysis

12.2 AstraZeneca plc

12.2.1 Overview
12.2.2 Recent Development
12.2.3 SWOT Analysis
12.2.4 Sales Analysis

12.3 Biocon

12.3.1 Overview
12.3.2 Recent Development
12.3.3 SWOT Analysis
12.3.4 Sales Analysis

12.4 Sanofi

12.4.1 Overview
12.4.2 Recent Development
12.4.3 SWOT Analysis
12.4.4 Sales Analysis

12.5 Eli Lilly

12.5.1 Overview
12.5.2 Recent Development
12.5.3 SWOT Analysis
12.5.4 Sales Analysis

12.6 Johnson & Johnson

12.6.1 Overview
12.6.2 Recent Development
12.6.3 SWOT Analysis
12.6.4 Sales Analysis

12.7 Bristol Myers Squibb Co.

12.7.1 Overview
12.7.2 Recent Development
12.7.3 SWOT Analysis
12.7.4 Sales Analysis

12.8 Novartis AG

12.8.1 Overview
12.8.2 Recent Development
12.8.3 SWOT Analysis
12.8.4 Sales Analysis



List of Figures

Figure-01: Global – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-03: Disease Type – Type 1 Diabetes Drug Market Market (Billion US$), 2018 – 2022
Figure-04: Disease Type – Forecast for Type 1 Diabetes Drug Market Market (Billion US$), 2023 – 2030
Figure-05: Disease Type – Type 2 Diabetes Drug Market Market (Billion US$), 2018 – 2022
Figure-06: Disease Type – Forecast for Type 2 Diabetes Drug Market Market (Billion US$), 2023 – 2030
Figure-07: Therapy – Oral Drugs Market (Billion US$), 2018 – 2022
Figure-08: Therapy – Forecast for Oral Drugs Market (Billion US$), 2023 – 2030
Figure-09: Therapy – (DPP) IV inhibitor Market (Billion US$), 2018 – 2022
Figure-10: Therapy – Forecast for (DPP) IV inhibitor Market (Billion US$), 2023 – 2030
Figure-11: Therapy – SGLT – 2 Market (Billion US$), 2018 – 2022
Figure-12: Therapy – Forecast for SGLT – 2 Market (Billion US$), 2023 – 2030
Figure-13: Therapy – Alpha Glucosidase Inhibitor Market (Million US$), 2018 – 2022
Figure-14: Therapy – Forecast for Alpha Glucosidase Inhibitor Market (Million US$), 2023 – 2030
Figure-15: Therapy – Biguanide Market (Million US$), 2018 – 2022
Figure-16: Therapy – Forecast for Biguanide Market (Million US$), 2023 – 2030
Figure-17: Therapy – Others Oral Drug Market (Billion US$), 2018 – 2022
Figure-18: Therapy – Forecast for Others Oral Drug Market (Billion US$), 2023 – 2030
Figure-19: Therapy – Injectable Drugs Market (Billion US$), 2018 – 2022
Figure-20: Therapy – Forecast for Injectable Drugs Market (Billion US$), 2023 – 2030
Figure-21: Therapy – Glucagon-like peptide (GLP) 1 agonist Market (Billion US$), 2018 – 2022
Figure-22: Therapy – Forecast for Glucagon-like peptide (GLP) 1 agonist Market (Billion US$), 2023 – 2030
Figure-23: Therapy – Amylin receptor agonist Market (Million US$), 2018 – 2022
Figure-24: Therapy – Forecast for Amylin receptor agonist Market (Million US$), 2023 – 2030
Figure-25: Therapy – Insulin Market (Billion US$), 2018 – 2022
Figure-26: Therapy – Forecast for Insulin Market (Billion US$), 2023 – 2030
Figure-27: Therapy – Rapid – Acting Insulin Market (Billion US$), 2018 – 2022
Figure-28: Therapy – Forecast for Rapid – Acting Insulin Market (Billion US$), 2023 – 2030
Figure-29: Therapy – Long Acting Insulin Market (Billion US$), 2018 – 2022
Figure-30: Therapy – Forecast for Long Acting Insulin Market (Billion US$), 2023 – 2030
Figure-31: Therapy – Premixed Insulin Market (Billion US$), 2018 – 2022
Figure-32: Therapy – Forecast for Premixed Insulin Market (Billion US$), 2023 – 2030
Figure-33: Therapy – Other Insulin Market (Billion US$), 2018 – 2022
Figure-34: Therapy – Forecast for Other Insulin Market (Billion US$), 2023 – 2030
Figure-35: United States – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-36: United States – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-37: Canada – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-38: Canada – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-39: France – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-40: France – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-41: Germany – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-42: Germany – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-43: Italy – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-44: Italy – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-45: Spain – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-46: Spain – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-47: UK – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-48: UK – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-49: Mexico – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-50: Mexico – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-51: Brazil – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-52: Brazil – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-53: Japan – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-54: Japan – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-55: South Korea – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-56: South Korea – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-57: China – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-58: China – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-59: India – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-60: India – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-61: Australia – Diabetes Drugs Market (Billion US$), 2018 – 2022
Figure-62: Australia – Forecast for Diabetes Drugs Market (Billion US$), 2023 – 2030
Figure-63: Vietnam – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-64: Vietnam – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-65: Malaysia – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-66: Malaysia – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-67: Indonesia – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-68: Indonesia – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-69: Philippines – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-70: Philippines – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-71: Thailand – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-72: Thailand – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-73: Saudi Arabia – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-74: Saudi Arabia – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-75: Iran – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-76: Iran – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-77: Egypt – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-78: Egypt – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-79: Oman – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-80: Oman – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-81: South Africa – Diabetes Drugs Market (Million US$), 2018 – 2022
Figure-82: South Africa – Forecast for Diabetes Drugs Market (Million US$), 2023 – 2030
Figure-83: Novo Nordisk – Global Revenue (Billion US$), 2018 – 2022
Figure-84: Novo Nordisk – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-85: AstraZeneca plc – Global Revenue (Billion US$), 2018 – 2022
Figure-86: AstraZeneca plc – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-87: Biocon – Global Revenue (Billion US$), 2018 – 2022
Figure-88: Biocon – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-89: Sanofi – Global Revenue (Billion US$), 2018 – 2022
Figure-90: Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-91: Eli Lilly – Global Revenue (Billion US$), 2018 – 2022
Figure-92: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-93: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2022
Figure-94: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-95: Bristol Myers Squibb Co. – Global Revenue (Billion US$), 2018 – 2022
Figure-96: Bristol Myers Squibb Co. – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-97: Novartis AG – Global Revenue (Billion US$), 2018 – 2022
Figure-98: Novartis AG – Forecast for Global Revenue (Billion US$), 2023 – 2030

List of Tables

Table-01: Global – Diabetes Drug Market Share by Disease Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Diabetes Drug Market Share by Disease Type (Percent), 2023 – 2030
Table-03: Global – Diabetes Drug Market Share by Therapy (Percent), 2018 – 2022
Table-04: Global – Forecast for Diabetes Drug Market Share by Therapy (Percent), 2023 – 2030
Table-05: Global – Diabetes Drug Market Share by Oral Drug (Percent), 2018 – 2022
Table-06: Global – Forecast for Diabetes Drug Market Share by Oral Drug (Percent), 2023 – 2030
Table-07: Global – Diabetes Drug Market Share by Injection Drug (Percent), 2018 – 2022
Table-08: Global – Forecast for Diabetes Drug Market Share by Injection Drug (Percent), 2023 – 2030
Table-09: Global – Diabetes Drug Market Share by Insulin (Percent), 2018 – 2022
Table-10: Global – Forecast for Diabetes Drug Market Share by Insulin (Percent), 2023 – 2030
Table-11: Global – Diabetes Drug Market Share by Countries (Percent), 2018 – 2022
Table-12: Global – Forecast for Diabetes Drug Market Share by Countries (Percent), 2023 – 2030